Solvay Sa · EURONEXT:SOLB

Solvay Sa — Q1 2022 Earnings Presentation

25 slides from Solvay Sa's earnings presentation, May 4, 2022

  1. Slide 1: First quarter 2022 Results

    Dr. Ilham Kadri CEO and President of the Executive Leadership Team of Solvay First quarter 2022 Results Karim Hajjar CFO of Solvay May 4, 2022 First Quarter 2022 Earnings

  2. Slide 2: Forenote

    Forenote This presentation may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this presentation is subject to risks and uncertainties relating to

  3. Slide 3: First quarter 2022 performance

    First quarter 2022 performance +26% sales growth driven by pricing leads to record EBITDA Free ROCE Net Sales EBITDA Underlying Cash Flow Return on capital employed Continuing operations € € € 3.1bn 712 m 216 m 12.3% ● +26% organically yoy ● Up by +20.1% organically yoy ● 12th quarter of positive FC

  4. Slide 4: Acceleration of strong pricing into 2022

    Acceleration of strong pricing into 2022 € 475m in price overcame €369m of inflationary costs In € million * Impact on net sales +77% QoQ +45% QoQ +25 +441 +475 -44 -466 -369 Net pricing +106 page 4 First Quarter 2022 Earnings

  5. Slide 5: Materials

    Materials Q1 2022 performance NET SALES EBITDA EBITDA y/y organic y/y organic margin Highlights + + 24 % 21 % 29 % • Specialty Polymers sales increased significantly to a new record, reflecting continued strong demand in all markets, and most notably automotive, batteries, medical devices, and electro

  6. Slide 6: Chemicals

    Chemicals Q1 2022 performance NET SALES EBITDA EBITDA y/y organic y/y organic margin Highlights + + 29 % 15 % 27 % • Higher sales in Soda Ash & Derivatives driven by strong demand and price actions, fully offsetting rising raw material and energy costs • Peroxides sales driven by strong demand in th

  7. Slide 7: Solutions

    Solutions Q1 2022 performance NET SALES y/y organic EBITDA y/y organic EBITDA margin Highlights • Novecare increased significantly driven by pricing and volume growth + + in agriculture, coatings, and home & personal care 26 % 35 % 21 % • Special Chem saw higher sales in electronics that were partial

  8. Slide 8: Structural cost reduction

    Structural cost reduction >80% of 2024 cost savings achieved Total costs savings to date ~€ Realized in FY 2020 Realized in FY 2021 Realized in Q1 2022 410 m ~€ ~€ ~€ 175m 213m 22m Costs savings target by 2024 € Permanent structural levers 500 m ● Restructuring ~45% of total ● Productivity efficienci

  9. Slide 9: Double-digit profit growth

    Double-digit profit growth € 712m in Q1 2022 vs. €583m in 2021 Net pricing Fixed costs Other Cost savings +15 Main drivers Inflation -30 Scope Forex Volume & mix Re-investments -30 conversion Indirect costs -15 • Pricing actions more than Others -25 offsetting variable costs inflation • Sustained momen

  10. Slide 10: Strong free cash flow generation

    Strong free cash flow generation Driven by profit, working capital discipline and reinvestments € 216m in Q1 2022 vs. € 282m in 2021 Capex Working capital Main drivers Provisions Financing • Higher profits Taxes €-39m Others €-44m • Investments in growth • Lower pensions and financing EBITDA FCF Q1 2022

  11. Slide 11: 2022 Full Year Outlook Upgraded

    2022 Full Year Outlook Upgraded EBITDA Free cash flow Underlying Continuing operations Mid-to-high single to exceed digit growth* € 650m (previously mid-single digit growth) (unchanged) * based on organic growth page 11 First Quarter 2022 Earnings

  12. Slide 12: Q&A

    O&A Y¥fno wl % solvay.com

  13. Slide 13: Annexes

    Annexes page 13 First Quarter 2022 Earnings

  14. Slide 14: Key figures & Segment review

    Key figures & Segment review Underlying, in € million Q1 2022 Q1 2021 % yoy Underlying, in € million Q1 2022 Q1 2021 % yoy % organic Net sales 3,055 2,373 +28.8% Net sales 3,055 2,373 +28.8% +26.1% EBITDA 712 583 +22.1% Materials 879 689 +27.6% +23.7% Specialty Polymers 671 511 +31.4% - EBITDA margin

  15. Slide 15: Strengthening our balance sheet

    Strengthening our balance sheet Reduction in net debt and provisions continue Net debt in million € vs end of 2021 Provisions in million € vs end of 2021 Underlying net debt down stable at €3.9 billion Provisions decreased by ~€160 million to €2.4 billion ● Higher free cash flow generation in 2021 ●

  16. Slide 16: Balanced maturities

    Balanced maturities Deleveraging and reduced of cost of debt Financial debt [1] in million € and $ NET DEBT Leverage ratio 1.6x S&P stable outlook Period 31 December 2021 31 March 2022 Variation over the period BBB Face value Avg. maturity Avg. cost Face value Avg. maturity Avg. cost Face value Avg.

  17. Slide 17: A balanced presence to better serve our customers

    A balanced presence to better serve our customers 2021 figures NORTH EUROPE AMERICA 27% 36 of net sales industrial sites 26% 36 of net sales industrial sites 47% 5 of Group major R&I centers 24% 3 employees of Group major R&I centers employees ASIA PACIFIC LATIN & Rest of the world* AMERICA 34% 20 of

  18. Slide 18: Market segment & region annual figures

    Market segment & region annual figures Region (% 2021 Net Sales) Group Materials Chemicals Solutions Europe 27% 31% 32% 21% North America 26% 31% 18% 29% TOP 3 Market position Latin America 13% 2% 25% 10% in ~ 90% of Asia and rest of the world 34% 36% 25% 40% portfolio End markets (% 2021 Net Sales)

  19. Slide 19: Three agile business segments to G.R.O.W. with our customers

    Three agile business segments to G.R.O.W. with our customers MATERIALS G CHEMICALS R SOLUTIONS O 34% of Group EBITDA1 39% of Group EBITDA1 27% of Group EBITDA1 Our unique portfolio of high- Our businesses are world-leaders in Thanks to our unique formulation performance polymers & composite essentia

  20. Slide 20: Reinventing Solvay to unleash our full potential

    Reinventing Solvay to unleash our full potential WHY HOW WHAT Our Our Our Our Purpose Strategy Organization Solutions and Culture We align our We bond people, G Growth technologies to customer ideas Our new common and societal needs driven and elements to operating model R Resilience by secular tren

  21. Slide 21: 2030 Solvay One Planet goals

    2030 Solvay One Planet goals 2021 results (Baseline 2018) 10 ambitious objectives to reduce our global impact Align greenhouse gas emissions Phase out coal Reduce with Paris Agreement & SBTi* (for energy pressure on CLIMATE Reach Carbon neutrality** production wherever biodiversity1 by 2040 excl. so

  22. Slide 22: Making meaningful progress on the climate

    Making meaningful progress on the climate Progress 2030 Target 2021 Comment versus 2018 targets Achieved 11% in aggregate versus 6.6% Paris Agreement -14% Reduce by 30% Align GHG emissions with Paris Agreement and SBTi (a) 11Mt -11% structural (-2.5%/yr) CLIMATE 27 Exit announced at Rheinberg in 202

  23. Slide 23: ESG credentials widely recognized

    ESG credentials widely recognized AA rating “Medium risk” Recognition on a scale from on Biodiversity AAA-CCC Member of FTSE4Good B rating #5 in the sector Prime company Top 1% A- CDP Climate Change page 23 First Quarter 2022 Earnings

  24. Slide 24: Why invest?

    Why invest? We aim to reshape the global Future growth potential Customer partnerships chemical industry by delivering fuelled by megatrends drive innovation solutions that meet the world’s sustainability challenges and provide critical solutions in fast-growth markets. Global scale, diversity of We

  25. Slide 25: Thank you.

    Thank you. Investor Relations Shareholders services [email protected] [email protected] Rue de Ransbeek, 310 Rue des Champs Elysées, 43 1120 Brussels, Belgium 1050 Brussels, Belgium Follow us on solvay.com

Solvay — Q1 2022 Earnings Presentation on 6ix